$5 HIV Prevention Pill: Merck’s Breakthrough Cost?
Merck’s Potential $5 HIV Prevention Pill Offers Hope for Global Access A groundbreaking analysis reveals that a novel HIV prevention pill, currently in development by Merck, could be manufactured for as little as $5 per patient annually. This dramatically low cost has ignited optimism among global health advocates, who believe it could pave the way … Read more